← 產業報告目錄
NGS Tumor Gene Analysis Software Industry Research Report 2026
出版商 APO Research產業別 Software & IT Services出版日期 2026-07-04頁數 122報告編號 APO-e64c370ff6
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global NGS Tumor Gene Analysis Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the NGS Tumor Gene Analysis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the NGS Tumor Gene Analysis Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the NGS Tumor Gene Analysis Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of NGS Tumor Gene Analysis Software include Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine and GTH.O, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global NGS Tumor Gene Analysis Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to NGS Tumor Gene Analysis Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
NGS Tumor Gene Analysis Software Market by Company
Roche
Illumina
Thermo Fisher Scientific
BGI Group
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
GTH.O
Golden Helix, Inc
Diatech Pharmacogenetics
ViennaLab Diagnostics GmbH
3D Medicines
NGS Tumor Gene Analysis Software Segment by Type
Non-Small Cell Lung Cancer
Human 6 Gene Mutations
Human 12 Gene Mutations
Other
NGS Tumor Gene Analysis Software Segment by Application
Hospitals and Health Systems
Research Institute
Other
NGS Tumor Gene Analysis Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NGS Tumor Gene Analysis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NGS Tumor Gene Analysis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NGS Tumor Gene Analysis Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of NGS Tumor Gene Analysis Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 NGS Tumor Gene Analysis Software by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Non-Small Cell Lung Cancer
2.2.3 Human 6 Gene Mutations
2.2.4 Human 12 Gene Mutations
2.2.5 Other
2.3 NGS Tumor Gene Analysis Software by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Hospitals and Health Systems
2.3.3 Research Institute
2.3.4 Other
2.4 Assumptions and Limitations
3 NGS Tumor Gene Analysis Software Breakdown Data by Type
3.1 Global NGS Tumor Gene Analysis Software Historic Market Size by Type (2021-2026)
3.2 Global NGS Tumor Gene Analysis Software Forecasted Market Size by Type (2027-2032)
4 NGS Tumor Gene Analysis Software Breakdown Data by Application
4.1 Global NGS Tumor Gene Analysis Software Historic Market Size by Application (2021-2026)
4.2 Global NGS Tumor Gene Analysis Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global NGS Tumor Gene Analysis Software Market Perspective (2021-2032)
5.2 Global NGS Tumor Gene Analysis Software Growth Trends by Region
5.2.1 Global NGS Tumor Gene Analysis Software Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 NGS Tumor Gene Analysis Software Historic Market Size by Region (2021-2026)
5.2.3 NGS Tumor Gene Analysis Software Forecasted Market Size by Region (2027-2032)
5.3 NGS Tumor Gene Analysis Software Market Dynamics
5.3.1 NGS Tumor Gene Analysis Software Industry Trends
5.3.2 NGS Tumor Gene Analysis Software Market Drivers
5.3.3 NGS Tumor Gene Analysis Software Market Challenges
5.3.4 NGS Tumor Gene Analysis Software Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top NGS Tumor Gene Analysis Software Players by Revenue
6.1.1 Global Top NGS Tumor Gene Analysis Software Players by Revenue (2021-2026)
6.1.2 Global NGS Tumor Gene Analysis Software Revenue Market Share by Players (2021-2026)
6.2 Global NGS Tumor Gene Analysis Software Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of NGS Tumor Gene Analysis Software Head Office and Area Served
6.4 Global NGS Tumor Gene Analysis Software Players, Product Type & Application
6.5 Global NGS Tumor Gene Analysis Software Manufacturers Established Date
6.6 Global NGS Tumor Gene Analysis Software Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America NGS Tumor Gene Analysis Software Market Size (2021-2032)
7.2 North America NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
7.4 North America NGS Tumor Gene Analysis Software Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe NGS Tumor Gene Analysis Software Market Size (2021-2032)
8.2 Europe NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
8.4 Europe NGS Tumor Gene Analysis Software Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific NGS Tumor Gene Analysis Software Market Size (2021-2032)
9.2 Asia-Pacific NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
9.4 Asia-Pacific NGS Tumor Gene Analysis Software Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America NGS Tumor Gene Analysis Software Market Size (2021-2032)
10.2 South America NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
10.4 South America NGS Tumor Gene Analysis Software Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa NGS Tumor Gene Analysis Software Market Size (2021-2032)
11.2 Middle East & Africa NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
11.4 Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Roche
12.1.1 Roche Company Information
12.1.2 Roche Business Overview
12.1.3 Roche Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.1.4 Roche NGS Tumor Gene Analysis Software Product Portfolio
12.1.5 Roche Recent Developments
12.2 Illumina
12.2.1 Illumina Company Information
12.2.2 Illumina Business Overview
12.2.3 Illumina Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.2.4 Illumina NGS Tumor Gene Analysis Software Product Portfolio
12.2.5 Illumina Recent Developments
12.3 Thermo Fisher Scientific
12.3.1 Thermo Fisher Scientific Company Information
12.3.2 Thermo Fisher Scientific Business Overview
12.3.3 Thermo Fisher Scientific Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.3.4 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product Portfolio
12.3.5 Thermo Fisher Scientific Recent Developments
12.4 BGI Group
12.4.1 BGI Group Company Information
12.4.2 BGI Group Business Overview
12.4.3 BGI Group Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.4.4 BGI Group NGS Tumor Gene Analysis Software Product Portfolio
12.4.5 BGI Group Recent Developments
12.5 Novogene
12.5.1 Novogene Company Information
12.5.2 Novogene Business Overview
12.5.3 Novogene Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.5.4 Novogene NGS Tumor Gene Analysis Software Product Portfolio
12.5.5 Novogene Recent Developments
12.6 Geneseeq
12.6.1 Geneseeq Company Information
12.6.2 Geneseeq Business Overview
12.6.3 Geneseeq Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.6.4 Geneseeq NGS Tumor Gene Analysis Software Product Portfolio
12.6.5 Geneseeq Recent Developments
12.7 AmoyDx
12.7.1 AmoyDx Company Information
12.7.2 AmoyDx Business Overview
12.7.3 AmoyDx Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.7.4 AmoyDx NGS Tumor Gene Analysis Software Product Portfolio
12.7.5 AmoyDx Recent Developments
12.8 Burning Rock Medicine
12.8.1 Burning Rock Medicine Company Information
12.8.2 Burning Rock Medicine Business Overview
12.8.3 Burning Rock Medicine Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.8.4 Burning Rock Medicine NGS Tumor Gene Analysis Software Product Portfolio
12.8.5 Burning Rock Medicine Recent Developments
12.9 GTH.O
12.9.1 GTH.O Company Information
12.9.2 GTH.O Business Overview
12.9.3 GTH.O Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.9.4 GTH.O NGS Tumor Gene Analysis Software Product Portfolio
12.9.5 GTH.O Recent Developments
12.10 Golden Helix, Inc
12.10.1 Golden Helix, Inc Company Information
12.10.2 Golden Helix, Inc Business Overview
12.10.3 Golden Helix, Inc Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.10.4 Golden Helix, Inc NGS Tumor Gene Analysis Software Product Portfolio
12.10.5 Golden Helix, Inc Recent Developments
12.11 Diatech Pharmacogenetics
12.11.1 Diatech Pharmacogenetics Company Information
12.11.2 Diatech Pharmacogenetics Business Overview
12.11.3 Diatech Pharmacogenetics Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.11.4 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product Portfolio
12.11.5 Diatech Pharmacogenetics Recent Developments
12.12 ViennaLab Diagnostics GmbH
12.12.1 ViennaLab Diagnostics GmbH Company Information
12.12.2 ViennaLab Diagnostics GmbH Business Overview
12.12.3 ViennaLab Diagnostics GmbH Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.12.4 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product Portfolio
12.12.5 ViennaLab Diagnostics GmbH Recent Developments
12.13 3D Medicines
12.13.1 3D Medicines Company Information
12.13.2 3D Medicines Business Overview
12.13.3 3D Medicines Revenue in NGS Tumor Gene Analysis Software Business (2021-2026)
12.13.4 3D Medicines NGS Tumor Gene Analysis Software Product Portfolio
12.13.5 3D Medicines Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global NGS Tumor Gene Analysis Software Revenue Market Share by Type (2021-2026)
Table 7. Global NGS Tumor Gene Analysis Software Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global NGS Tumor Gene Analysis Software Revenue Market Share by Type (2027-2032)
Table 9. Global NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global NGS Tumor Gene Analysis Software Revenue Market Share by Application (2021-2026)
Table 11. Global NGS Tumor Gene Analysis Software Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global NGS Tumor Gene Analysis Software Revenue Market Share by Application (2027-2032)
Table 13. Global NGS Tumor Gene Analysis Software Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global NGS Tumor Gene Analysis Software Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global NGS Tumor Gene Analysis Software Market Share by Region (2021-2026)
Table 16. Global NGS Tumor Gene Analysis Software Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global NGS Tumor Gene Analysis Software Market Share by Region (2027-2032)
Table 18. NGS Tumor Gene Analysis Software Industry Trends
Table 19. NGS Tumor Gene Analysis Software Industry Drivers
Table 20. NGS Tumor Gene Analysis Software Industry Opportunities and Challenges
Table 21. NGS Tumor Gene Analysis Software Market Restraints
Table 22. Global Top NGS Tumor Gene Analysis Software Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global NGS Tumor Gene Analysis Software Revenue Market Share by Players (2021-2026)
Table 24. Global NGS Tumor Gene Analysis Software Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of NGS Tumor Gene Analysis Software, Headquarters and Area Served
Table 26. Global NGS Tumor Gene Analysis Software Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global NGS Tumor Gene Analysis Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America NGS Tumor Gene Analysis Software Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe NGS Tumor Gene Analysis Software Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific NGS Tumor Gene Analysis Software Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific NGS Tumor Gene Analysis Software Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America NGS Tumor Gene Analysis Software Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa NGS Tumor Gene Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2027-2032) & (US$ Million)
Table 45. Roche Company Information
Table 46. Roche Business Overview
Table 47. Roche Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 48. Roche NGS Tumor Gene Analysis Software Product Portfolio
Table 49. Roche Recent Developments
Table 50. Illumina Company Information
Table 51. Illumina Business Overview
Table 52. Illumina Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 53. Illumina NGS Tumor Gene Analysis Software Product Portfolio
Table 54. Illumina Recent Developments
Table 55. Thermo Fisher Scientific Company Information
Table 56. Thermo Fisher Scientific Business Overview
Table 57. Thermo Fisher Scientific Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 58. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product Portfolio
Table 59. Thermo Fisher Scientific Recent Developments
Table 60. BGI Group Company Information
Table 61. BGI Group Business Overview
Table 62. BGI Group Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 63. BGI Group NGS Tumor Gene Analysis Software Product Portfolio
Table 64. BGI Group Recent Developments
Table 65. Novogene Company Information
Table 66. Novogene Business Overview
Table 67. Novogene Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 68. Novogene NGS Tumor Gene Analysis Software Product Portfolio
Table 69. Novogene Recent Developments
Table 70. Geneseeq Company Information
Table 71. Geneseeq Business Overview
Table 72. Geneseeq Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 73. Geneseeq NGS Tumor Gene Analysis Software Product Portfolio
Table 74. Geneseeq Recent Developments
Table 75. AmoyDx Company Information
Table 76. AmoyDx Business Overview
Table 77. AmoyDx Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 78. AmoyDx NGS Tumor Gene Analysis Software Product Portfolio
Table 79. AmoyDx Recent Developments
Table 80. Burning Rock Medicine Company Information
Table 81. Burning Rock Medicine Business Overview
Table 82. Burning Rock Medicine Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 83. Burning Rock Medicine NGS Tumor Gene Analysis Software Product Portfolio
Table 84. Burning Rock Medicine Recent Developments
Table 85. GTH.O Company Information
Table 86. GTH.O Business Overview
Table 87. GTH.O Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 88. GTH.O NGS Tumor Gene Analysis Software Product Portfolio
Table 89. GTH.O Recent Developments
Table 90. Golden Helix, Inc Company Information
Table 91. Golden Helix, Inc Business Overview
Table 92. Golden Helix, Inc Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 93. Golden Helix, Inc NGS Tumor Gene Analysis Software Product Portfolio
Table 94. Golden Helix, Inc Recent Developments
Table 95. Diatech Pharmacogenetics Company Information
Table 96. Diatech Pharmacogenetics Business Overview
Table 97. Diatech Pharmacogenetics Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 98. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product Portfolio
Table 99. Diatech Pharmacogenetics Recent Developments
Table 100. ViennaLab Diagnostics GmbH Company Information
Table 101. ViennaLab Diagnostics GmbH Business Overview
Table 102. ViennaLab Diagnostics GmbH Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 103. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product Portfolio
Table 104. ViennaLab Diagnostics GmbH Recent Developments
Table 105. 3D Medicines Company Information
Table 106. 3D Medicines Business Overview
Table 107. 3D Medicines Revenue in NGS Tumor Gene Analysis Software Business (2021-2026) & (US$ Million)
Table 108. 3D Medicines NGS Tumor Gene Analysis Software Product Portfolio
Table 109. 3D Medicines Recent Developments
Table 110. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. NGS Tumor Gene Analysis Software Product Image
Figure 5. Global NGS Tumor Gene Analysis Software Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global NGS Tumor Gene Analysis Software Market Share by Type: 2025 VS 2032
Figure 7. Non-Small Cell Lung Cancer Product
Figure 8. Human 6 Gene Mutations Product
Figure 9. Human 12 Gene Mutations Product
Figure 10. Other Product
Figure 11. Global NGS Tumor Gene Analysis Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global NGS Tumor Gene Analysis Software Market Share by Application: 2025 VS 2032
Figure 13. Hospitals and Health Systems Product
Figure 14. Research Institute Product
Figure 15. Other Product
Figure 16. Global NGS Tumor Gene Analysis Software Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 17. Global NGS Tumor Gene Analysis Software Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 18. Global NGS Tumor Gene Analysis Software Market Share by Region: 2025 VS 2032
Figure 19. Global NGS Tumor Gene Analysis Software Market Share by Players in 2025
Figure 20. Global NGS Tumor Gene Analysis Software Manufacturers Established Date
Figure 21. Global Top 5 and 10 NGS Tumor Gene Analysis Software Players Market Share by Revenue in 2025
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. North America NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. North America NGS Tumor Gene Analysis Software Market Share by Country (2021-2032)
Figure 25. United States NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Canada NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Mexico NGS Tumor Gene Analysis Software Market Share by Country (2021-2032)
Figure 28. Europe NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. Europe NGS Tumor Gene Analysis Software Market Share by Country (2021-2032)
Figure 30. Germany NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. France NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. U.K. NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Italy NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Spain NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Russia NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Netherlands NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Nordic Countries NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific NGS Tumor Gene Analysis Software Market Share by Country (2021-2032)
Figure 40. China NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. Japan NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. South Korea NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India NGS Tumor Gene Analysis Software Market Share by Country (2021-2032)
Figure 45. Australia NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. China Taiwan NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. Southeast Asia NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America NGS Tumor Gene Analysis Software Market Share by Country (2021-2032)
Figure 50. Brazil NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Argentina NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Chile NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Colombia NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Peru NGS Tumor Gene Analysis Software Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Roche Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 56. Illumina Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 58. BGI Group Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 59. Novogene Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 60. Geneseeq Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 61. AmoyDx Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 62. Burning Rock Medicine Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 63. GTH.O Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 64. Golden Helix, Inc Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 65. Diatech Pharmacogenetics Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 66. ViennaLab Diagnostics GmbH Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
Figure 67. 3D Medicines Revenue Growth Rate in NGS Tumor Gene Analysis Software Business (2021-2026)
提及公司
RocheIlluminaThermo Fisher ScientificBGI GroupNovogeneGeneseeqAmoyDxBurning Rock MedicineGTH.OGolden Helix, IncDiatech PharmacogeneticsViennaLab Diagnostics GmbH3D Medicines
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們